More importantly, our results indicate that MeBlu, an organic dye in clinical use for some therapeutic applications in the developed world (Clifton and Leikin, 2003; Schirmer et al., 2011; Bistas and Sanghavi, 2020) and with additional potential for certain developing world applications such as malaria (Dicko et al., 2018), can inhibit the viral attachment and entry of SARS-CoV-2 by blocking the PPI of its spike protein with ACE2 on the host cell. This evidence concerns the gene ACE2 and malaria.